Please use this identifier to cite or link to this item:
|Title:||Cardioprotective aspirin in type 2 diabetes|
|Citation:||Medicine Today, 2012; 13(1):44-47|
|Leslie Jackowski, Dan Worthley, Pat Phillips|
|Abstract:||There is strong evidence supporting the use of low-dose aspirin in the secondary prevention of cardiovascular events in patients with type, diabetes but the evidence is less robust in primary prevention. Also, aspirin use can be associated with serious gastrointestinal haemorrhage.|
|Rights:||Medicine Today Pty Ltd|
|Appears in Collections:||General Practice publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.